Tatsiana Beiko to National Heart, Lung, and Blood Institute (U.S.)
This is a "connection" page, showing publications Tatsiana Beiko has written about National Heart, Lung, and Blood Institute (U.S.).
Connection Strength
0.049
-
Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry. Int J Chron Obstruct Pulmon Dis. 2020; 15:3193-3199.
Score: 0.049